Medical stocks and pharmaceutical plates
Medical stocks and pharmaceutical plates, which requires access to relevant information in order to answer the answer, according to years of learning experience, if the answer to the medical stocks and pharmaceutical plates, can make you twice as easy as twice as easy, the following share of medical stocks and pharmaceutical plates related to the methodology of the experience for your reference.
Medical Stocks and Pharmaceutical Sector
Medical Stocks and Pharmaceutical Sector is a sector that consists of listed companies in the pharmaceutical sector. The stocks in the pharmaceutical sector are generally characterized by the pharmaceutical industry, i.e., they all have the attributes of pharmaceutical manufacturing or pharmaceutical distribution.
The industry chain of listed companies within the pharmaceutical sector is also diversified, including companies engaged in pharmaceutical research and development, medical devices, and drug distribution.
The trend of the healthcare industry and the pharmaceutical sector may be affected by factors such as macroeconomics, industry policies, healthcare insurance funding, and an aging population. These factors may prompt investors to pay attention to or participate in the sector.
Investors who participate in investing in the pharmaceutical sector need to conduct in-depth research and analysis of relevant industry information and company fundamentals in order to make rational investment decisions.
Medical Stocks White Horse Stocks List
Medical stocks white horse stocks include, but are not limited to, the following categories:
______ Hengrui Medicine. ____ Domestic chemical pharmaceutical strength ranked first, the national key research and development program lead unit.
______ Changchun High-Tech. ____ growth hormone leader, with monopoly advantage.
______ Aier Ophthalmology. ____ China's eye hospitals, the first market capitalization.
______Tongze Medical. ____ The only hospital with the layout of the whole oral industry chain.
______ Meikang Bio. ____ A leading domestic manufacturer and distributor of medical diagnostic reagents and instruments.
______ Chutian Technology. ____ provides instruments, reagents and pathology diagnostic services in the field of medical diagnosis.
______ Davy Medical. ____ Manufactures and sells in the field of newborn care products.
______Colon Pharmaceuticals. ____ blood products, especially static C has a greater advantage, 2022Q1 signed a large contract of API export to Europe, with long-term logic, belongs to the blood products plate in the scarcity of the standard.
______ Kangtai biology. ____ the smallest vaccine marker in the market, inactivated vaccines stuck the vast majority of the market, the subsequent 3 inactivated vaccines will be listed.
______Watson Bio. ____ the second smallest vaccine target in the market, previously excellent clinical results of 2-valent HPV vaccine, the only 2-valent HPV vaccine in the market at present has the advantage of the company, in addition to the 4-valent influenza virus vaccine also has a good market space.
______ Hualan Bio. ____ domestic blood products leader, blood products inventory ranks first in the industry, the most plasma stations, the disadvantage is less genetically engineered vaccines.
______Tiantan Bio. ____st Tiantan Holdings has the strongest vaccine asset injection expectations, including some of the vaccines of Tiantan Anke Biologicals, as well as the 13-valent pneumonia vaccine and tetravalent influenza vaccine under development.
______Hualan Vaccine. ____ Hualan Biological subsidiary of the vaccine subsidiary, there are influenza vaccine and DPT vaccine, chickenpox vaccine, measles, mumps, rubella vaccine, etc., and recently in the development of the 13-valent pneumonia vaccine and 4-valent influenza vaccine progress faster.